Conference Dates: Sep 13-16, 2010
Arlington, VA[edit Location]
As pressure mounts to accelerate drug development while also reducing costs and to offer more personalized patient treatment, there is increased emphasis on the importance of bridging drug and diagnostic development, leveraging emerging technologies to provide earlier and more individualized diagnosis and prognosis, and re-designing drug development to allow earlier and more efficient decision making. The ADAPT 2010: Accelerating Development & Advancing Personalized Therapy Congress is designed to bridge multiple disciplines, while providing in-depth coverage of personalized medicine, cancer, biomarkers, diagnostics, and clinical trials.
Launched last year, ADAPT Congress brought together a mix of long-running events along with new ones, and immediately attracted over 450 delegates from 275+ organizations, representing 20+ countries. This year, we are expanding the program further with additional coverage of diagnostics, personalized medicine and cancer to produce a growing and comprehensive event that attracts a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers, making ADAPT 2010 Congress a perfect meeting-place to learn about cutting-edge research from leading experts, share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
[edit description]Click here to register.[edit ]
Industries[edit]
Fee: $1995[edit ]
Web Presences[edit]
| Early Bird Registration Deadline: | Apr 23, 2010 |
| Early Bird Registration Deadline: | Jun 18, 2010 |
| Advance Registration Deadline: | Aug 06, 2010 |
| Start Date: | Sep 13, 2010 |
| End Date: | Sep 16, 2010 |